2019
DOI: 10.1002/ange.201900366
|View full text |Cite
|
Sign up to set email alerts
|

Boosting Non‐Radiative Decay to Do Useful Work: Development of a Multi‐Modality Theranostic System from an AIEgen

Abstract: The efficient utilization of energy dissipating from non-radiative excited-state decayo ff luorophores was only rarely reported. Herein, we demonstrate how to boost the energy generation of non-radiative decayand use it for cancer theranostics.Anovel compound (TFM) was synthesized which possesses arotor-like twisted structure,strong absorption in the far red/near-infrared region, and it shows aggregation-induced emission (AIE). Molecular dynamics simulations reveal that the TFM aggregate is in an amorphous for… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
21
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
8
1

Relationship

5
4

Authors

Journals

citations
Cited by 52 publications
(21 citation statements)
references
References 39 publications
0
21
0
Order By: Relevance
“…Although this is troublesome upon most occasions, we can smartly take advantage of this non-radiative decay energy by installing molecular rotors for potential PTT, PTI and PAI applications. [28][29][30][31] Additionally, as molecules with long emission wavelength generally have narrowed highest occupied and lowest unoccupied molecular orbital (HOMO-LUMO) bandgaps accompanying with relatively small singlet-triplet energy gaps (ΔEST), reactive singlet oxygen (ROS) species production is facilitated as a result of high intersystem crossing yield, which is beneficial for photodynamic therapy (PDT). [32][33][34] Therefore, through structural design and regulation, we are able to make the best use of excited state energy of the AIEgen to construct an ideal multi-modality theranostic platform.…”
Section: Making the Best Use Of Excited-state Energy: Multimodality Theranostic Systems Based On Nir-ii Aiegensmentioning
confidence: 99%
“…Although this is troublesome upon most occasions, we can smartly take advantage of this non-radiative decay energy by installing molecular rotors for potential PTT, PTI and PAI applications. [28][29][30][31] Additionally, as molecules with long emission wavelength generally have narrowed highest occupied and lowest unoccupied molecular orbital (HOMO-LUMO) bandgaps accompanying with relatively small singlet-triplet energy gaps (ΔEST), reactive singlet oxygen (ROS) species production is facilitated as a result of high intersystem crossing yield, which is beneficial for photodynamic therapy (PDT). [32][33][34] Therefore, through structural design and regulation, we are able to make the best use of excited state energy of the AIEgen to construct an ideal multi-modality theranostic platform.…”
Section: Making the Best Use Of Excited-state Energy: Multimodality Theranostic Systems Based On Nir-ii Aiegensmentioning
confidence: 99%
“…TPA‐FO and TPA‐PDO in Scheme 1 were synthesized by a one‐step Suzuki coupling reaction, and the corresponding route is presented in Scheme S1, [ 23 ] and the synthetic cost was calculated in Table S1. TPA‐FO and TPA‐PDO consist of TPA as D units, and carbonyl group‐functionalized arenes, fluorenone and phenanthrenedione, as the rigid planar A units, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…[ 10 ] Moreover, most NIR‐II AIEgens adopt an electron donating‐accepting‐donating (D‐A‐D) type structure with benzo[1,2‐c:4,5‐c′]bis([1,2,5]thiadiazole) as electron accepting unit, therefore, further improvement on molecular diversity is still called for. [ 11 ] Additionally, in view of the fact that FLI‐guided phototherapy involving photodynamic therapy (PDT) and/or photothermal therapy (PTT) has been recognized to be a promising strategy for simultaneous disease diagnosis and therapy, especially for cancer theranostics, [ 12 ] developing effective AIE photosensitizer for NIR‐II FLI‐guided synergistic phototherapy remains an needed task with very limited success. [ 13 ]…”
Section: Introductionmentioning
confidence: 99%